BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · Real-Time Price · USD
62.74
+0.80 (1.29%)
Apr 24, 2025, 4:00 PM EDT - Market closed
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Voxzogo | 734.60M | 672.30M | 605.50M | 534.90M | 469.80M | 390.90M | 316.20M | 237.30M | ||||||||||
| Voxzogo Growth | 56.36% | 71.99% | 91.49% | 125.41% | 177.66% | 261.61% | 427.88% | 830.59% | ||||||||||
| Vimizom | - | 724.30M | 705.00M | 704.40M | 701.10M | 677.50M | 674.10M | 669.90M | 663.80M | |||||||||
| Vimizom Growth | - | 6.91% | 4.58% | 5.15% | 5.62% | 1.39% | 3.80% | 3.40% | 6.53% | |||||||||
| Naglazyme | 479.50M | 467.80M | 444.80M | 402.90M | 420.30M | 422.50M | 413.10M | 438.80M | ||||||||||
| Naglazyme Growth | 14.09% | 10.72% | 7.67% | -8.18% | -5.30% | -0.91% | 3.77% | 9.40% | ||||||||||
| Palynziq | 354.60M | 342.40M | 330.70M | 317.30M | 304.00M | 288.50M | 275.80M | 262.50M | ||||||||||
| Palynziq Growth | 16.64% | 18.68% | 19.91% | 20.88% | 19.22% | 17.04% | 14.44% | 10.16% | ||||||||||
| Aldurazyme | 183.90M | 187.60M | 130.40M | 132.10M | 131.20M | 126.20M | 141.40M | 138.40M | ||||||||||
| Aldurazyme Growth | 40.17% | 48.65% | -7.78% | -4.55% | 2.18% | 13.80% | 33.02% | 42.53% | ||||||||||
| Brineura | 169.30M | 164.90M | 168.90M | 161.70M | 161.80M | 160.80M | 157.60M | 157.20M | ||||||||||
| Brineura Growth | 4.64% | 2.55% | 7.17% | 2.86% | 4.86% | 7.85% | 9.22% | 14.83% | ||||||||||
| Kuvan | 120.60M | 129.30M | 144.10M | 166.10M | 180.70M | 197.60M | 211.70M | 218.70M | ||||||||||
| Kuvan Growth | -33.26% | -34.56% | -31.93% | -24.05% | -20.57% | -18.48% | -16.36% | -20.27% | ||||||||||
| Royalty and Other | 44.48M | 45.90M | 47.10M | 47.80M | 46.80M | 45.70M | 44.60M | 50.10M | ||||||||||
| Royalty and Other Growth | -4.96% | 0.44% | 5.61% | -4.59% | -13.17% | -19.12% | -24.92% | -14.07% | ||||||||||
| Roctavian | 26.40M | 18.10M | 11.70M | 4.30M | 3.50M | 800.00K | - | - | ||||||||||
| Roctavian Growth | 654.29% | 2,162.50% | - | - | - | - | - | - |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.